Acrux Limited (ACR)

Location:: Melbourne, Australia
Market Cap:: $7 million
Sector:: Health Care
Website:: www.acrux.com.au

Share Price & Volume

Latest Open Briefings

17 Aug 2018
2018 Full-Year Results Investor Conference Call
21 Feb 2018
2018 Half-Year Results Investor Conference Call
24 Aug 2017
Acrux Full Year 2017 Financial Results
21 Feb 2017
Half Year Investor Conference Call
25 Aug 2016
2016 Annual Results

Load next 5 items

Latest Market Announcements

08:38 24 Nov
Notification of cessation of securities - ACR
08:37 24 Nov
Appendix 3Y Oldham
08:36 24 Nov
Appendix 3Y Brumley
08:36 24 Nov
Application for quotation of securities - ACR
08:21 13 Nov
Acrux receives $0.4m advance on FY26 R&D Tax Incentive

Load next 5 items

ASX Announcements delayed by 20 minutes.

You may also be interested in...

View all

Other Open Briefings in the Health Care Sector

20 Nov 2025
AFT Pharmaceuticals - ASX Listing (AFP)
FY2026 Half Year Results Analyst Briefing
25 Aug 2025
Ansell Limited (ANN)
Ansell FY25 Full Year Results Briefing
22 Aug 2025
Monash IVF Group Limited (MVF)
Monash IVF Group Limited FY25 Full Year Results announcement
21 Aug 2025
Healius Limited (HLS)
Healius FY25 Results
01 Aug 2025
AFT Pharmaceuticals - ASX Listing (AFP)
AFT Pharmaceuticals 2025 Annual General Meeting
22 May 2025
AFT Pharmaceuticals - ASX Listing (AFP)
FY2025 Full Year Results Analyst Briefing
27 Mar 2025
Healius Limited (HLS)
Healius Investor Day
27 Feb 2025
Monash IVF Group Limited (MVF)
Monash IVF Group Limited FY25 Half Year Results announcement
20 Feb 2025
Healius Limited (HLS)
Healius 1H25 Results
21 Nov 2024
AFT Pharmaceuticals - ASX Listing (AFP)
FY2025 Half Year Results Analyst Briefing

About Us

Open Briefing is an online investor communication platform that provides ASX listed companies with a dedicated site for hosting, distributing and archiving important market updates and provides investors with a central resource for increasing their understanding of a company's fundamentals and strategic direction. Read more

Stay Informed

Subscribe to receive the latest Open Briefings